FHH-Chr 1BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
9 |
|
0.33 |
IU/g |
0.1 |
0.3 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47373 |
461 |
FHH-Chr 1BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
|
15.29 |
ml/min/g |
0.72 |
2.27 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46679 |
461 |
FHH-Chr 1BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
9 |
|
0.34 |
IU/g |
0.06 |
0.19 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47486 |
461 |
FHH-Chr 1BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
10 |
|
0.39 |
IU/g |
0.08 |
0.27 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47511 |
461 |
FHH-Chr 1BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
8 |
|
0.21 |
IU/g |
0.04 |
0.11 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47350 |
461 |
FHH-Chr 1BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
|
7.43 |
ml/min/g |
0.25 |
0.79 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
44744 |
461 |
FHH-Chr 1BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
|
12.92 |
ml/min/g |
1.26 |
3.79 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46896 |
461 |
FHH-Chr 1BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
|
12.46 |
ml/min/g |
0.9 |
2.85 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46885 |
461 |
FHH-Chr 1BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
|
14.88 |
ml/min/g |
1.14 |
3.59 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46668 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
47.68 |
% |
2.98 |
9.41 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47092 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
54.91 |
% |
3.73 |
11.2 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46092 |
461 |
FHH-Chr 1BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
|
7.06 |
ml/min/g |
0.69 |
2.19 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
44733 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
55.37 |
% |
3.7 |
11.71 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46081 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
49.61 |
% |
2.83 |
8.95 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47103 |
461 |
FHH-Chr 1BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
|
7.05 |
ml/min/g |
0.94 |
2.97 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46216 |
461 |
FHH-Chr 1BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
|
7.15 |
ml/min/g |
0.93 |
2.79 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46227 |
461 |